EP2709991
Use of cxcr4 antagonists for treating WHIM syndrome, myelokathexis, neutropenia and lymphocytopenia
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
15.5.2012EP published:
2.9.2020EP application number:
12786739.8
EPO information:
European Patent Register
Max expiry date:
14.5.2032
Title:
Use of cxcr4 antagonists for treating WHIM syndrome, myelokathexis, neutropenia and lymphocytopenia
Timeline
Today
15.5.2012EP application
2.9.2020EP Publication
Owner
Name:
Genzyme CorporationAddress:
50 Binney Street, Cambridge, MA 02142, US
Name:
University of WashingtonAddress:
Center for Commercialization 4311 11th Avenue NE, Suite 500, Seattle, WA 98105, US
Inventor
Name:
DALE, David, C.Address:
Seattle, WA 98105, US
Name:
BRIDGER, Gary, J.Address:
Bellingham, WA 98225, US
Name:
HSU, Frank, J.Address:
Cambridge, MA 02142, US
Priority
Number:
201161486632 PDate:
16.5.2011Country:
US
Classification
Categories:
A61K 31/395, A61P 7/06, C07D 255/02, A61K 45/06, A61K 38/19